HUP0102853A3 - Compounds from moraxella catarrhalis - Google Patents

Compounds from moraxella catarrhalis

Info

Publication number
HUP0102853A3
HUP0102853A3 HU0102853A HUP0102853A HUP0102853A3 HU P0102853 A3 HUP0102853 A3 HU P0102853A3 HU 0102853 A HU0102853 A HU 0102853A HU P0102853 A HUP0102853 A HU P0102853A HU P0102853 A3 HUP0102853 A3 HU P0102853A3
Authority
HU
Hungary
Prior art keywords
compounds
moraxella catarrhalis
catarrhalis
moraxella
Prior art date
Application number
HU0102853A
Other languages
English (en)
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of HUP0102853A1 publication Critical patent/HUP0102853A1/hu
Publication of HUP0102853A3 publication Critical patent/HUP0102853A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0102853A 1998-05-13 1999-05-07 Compounds from moraxella catarrhalis HUP0102853A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810285.8A GB9810285D0 (en) 1998-05-13 1998-05-13 Novel compounds
PCT/EP1999/003257 WO1999058684A2 (en) 1998-05-13 1999-05-07 Compounds from moraxella catarrhalis

Publications (2)

Publication Number Publication Date
HUP0102853A1 HUP0102853A1 (hu) 2001-11-28
HUP0102853A3 true HUP0102853A3 (en) 2008-04-28

Family

ID=10831997

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102853A HUP0102853A3 (en) 1998-05-13 1999-05-07 Compounds from moraxella catarrhalis

Country Status (23)

Country Link
US (2) US7122197B1 (hu)
EP (1) EP1078064B1 (hu)
JP (1) JP4503175B2 (hu)
KR (1) KR100610448B1 (hu)
CN (3) CN1210401C (hu)
AT (1) ATE303442T1 (hu)
AU (1) AU737196B2 (hu)
BR (1) BR9911773A (hu)
CA (1) CA2328502A1 (hu)
CZ (1) CZ298227B6 (hu)
DE (1) DE69927017T2 (hu)
DK (1) DK1078064T3 (hu)
ES (1) ES2247803T3 (hu)
GB (1) GB9810285D0 (hu)
HK (1) HK1036299A1 (hu)
HU (1) HUP0102853A3 (hu)
IL (2) IL139612A0 (hu)
NO (1) NO330169B1 (hu)
NZ (1) NZ508322A (hu)
PL (1) PL199497B1 (hu)
TR (1) TR200003345T2 (hu)
WO (1) WO1999058684A2 (hu)
ZA (1) ZA200006522B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
SI2255826T1 (sl) 2002-08-02 2016-07-29 Glaxosmithkline Biologicals S.A. Neisserijski vakcinski sestavki, ki obsegajo kombinacijo antigenov
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
CN111003884B (zh) * 2019-12-05 2021-12-31 浙江海洋大学 重金属污水处理设备及处理方法
CN114703214A (zh) * 2022-03-03 2022-07-05 南京吉芮康生物科技研究院有限公司 一种抗丢失时空可控表达的新型质粒及其应用
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552146A (en) * 1991-08-15 1996-09-03 Board Of Regents, The University Of Texas System Methods and compositions relating to useful antigens of Moraxella catarrhalis
US5712118A (en) 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
US6440425B1 (en) * 1995-05-01 2002-08-27 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella
US6607731B1 (en) * 1995-09-22 2003-08-19 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
US7341727B1 (en) * 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
AU740481B2 (en) * 1996-08-12 2001-11-08 Board Of Regents, The University Of Texas System Defining epitopes of the outer membrane protein CopB of moraxella catarrhalis
US6673910B1 (en) 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
WO2000078968A2 (en) 1999-06-18 2000-12-28 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Also Published As

Publication number Publication date
IL139612A0 (en) 2002-02-10
CZ20004203A3 (en) 2001-05-16
PL199497B1 (pl) 2008-09-30
ES2247803T3 (es) 2006-03-01
US7122197B1 (en) 2006-10-17
ATE303442T1 (de) 2005-09-15
CA2328502A1 (en) 1999-11-18
IL139612A (en) 2007-07-24
DE69927017T2 (de) 2006-03-16
PL344792A1 (en) 2001-11-19
KR20010043573A (ko) 2001-05-25
CZ298227B6 (cs) 2007-07-25
US20060147462A1 (en) 2006-07-06
DK1078064T3 (da) 2006-01-02
HUP0102853A1 (hu) 2001-11-28
CN1727359A (zh) 2006-02-01
EP1078064B1 (en) 2005-08-31
HK1036299A1 (en) 2001-12-28
DE69927017D1 (de) 2005-10-06
CN1309706A (zh) 2001-08-22
JP2002514425A (ja) 2002-05-21
TR200003345T2 (tr) 2001-03-21
EP1078064A2 (en) 2001-02-28
GB9810285D0 (en) 1998-07-15
AU737196B2 (en) 2001-08-09
WO1999058684A3 (en) 2000-02-24
KR100610448B1 (ko) 2006-08-09
NZ508322A (en) 2002-12-20
ZA200006522B (en) 2001-11-29
JP4503175B2 (ja) 2010-07-14
NO330169B1 (no) 2011-02-28
NO20005697L (no) 2001-01-10
AU4142199A (en) 1999-11-29
WO1999058684A2 (en) 1999-11-18
NO20005697D0 (no) 2000-11-10
CN1210401C (zh) 2005-07-13
CN100484956C (zh) 2009-05-06
BR9911773A (pt) 2002-03-05
CN1876679A (zh) 2006-12-13

Similar Documents

Publication Publication Date Title
HRP20010412B1 (en) New esters derived from substituted phenyl-cyclohexyl compounds
GB9803411D0 (en) Novel compounds
GB9801392D0 (en) Novel compounds
GB2342667B (en) Debris removal from wellbores
HUP0102853A3 (en) Compounds from moraxella catarrhalis
AU4033199A (en) Polypeptides from moraxella (branhamella) catarrhalis
AU4260099A (en) Compounds from moraxella catarrhalis
SI1078064T1 (sl) Spojine iz Moraxella catarrhalis
GB9803751D0 (en) Novel compounds
AU6151900A (en) Moraxella catarrhalis polypeptides
TW346283U (en) Wiring-separated trough
GB9802657D0 (en) Novel compounds
GB9803287D0 (en) Novel compounds
GB9803786D0 (en) Novel compounds
GB9803782D0 (en) Novel compounds
GB9803779D0 (en) Novel compounds
GB9800317D0 (en) Novel compounds
GB9800337D0 (en) Novel compounds
GB9803772D0 (en) Novel compounds
GB9818458D0 (en) Novel compounds
GB9801630D0 (en) Novel compounds
GB9800289D0 (en) Novel compounds
GB9803567D0 (en) Novel compounds
GB9803566D0 (en) Novel compounds
GB9801633D0 (en) Novel compounds

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished